Nr1d1 knockdown120 or treatment with the REV-ERBα agonist SR9009121 accelerated (≈1.5-fold) or suppressed atherosclerosis and reduced the acquisition of a proinflammatory phenotype in macrophages, respectively. Here, NR1D1 is linked to atherosclerosis.